Divi's Laboratories Limited

5,750.1

INR
-20.00(-0.35%)
As of November 14, 2024 10:00:00 AM

About Divi's Laboratories Limited

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
19.09x
Operating MarginLast 12 months
24.83
+20.8% quarterly YoY
Market Cap
156270.99 CrINR
Employees
9741
CEO
Dr. Kiran Satchandra Divi B. Pharm., M.Pharm
Website

Divi's Laboratories Limited

5,750.1

INR
-20.00(-0.35%)
As of November 14, 2024 10:00:00 AM

About Divi's Laboratories Limited

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
19.09x
Operating MarginLast 12 months
24.83
+20.8% quarterly YoY
Market Cap
156270.99 CrINR
Employees
9741
CEO
Dr. Kiran Satchandra Divi B. Pharm., M.Pharm
Website